Changes

Jump to navigation Jump to search
1,757 bytes added ,  12:23, 12 September 2012
added 4V cannulation method
Line 13: Line 13:  
===Method===
 
===Method===
   −
Each rat was stereotaxically implanted with a 22 gauge, stainless steel, guide
+
Each rat was stereotaxically implanted with a 22-gauge, stainless steel, guide
−
cannula (Plastics One, Roanoke, VA) aimed towards the
+
cannula (Plastics One, Roanoke, VA) aimed towards the lateral cerebral ventricle (1.2 mm caudal to bregma, 1.5 mm
−
lateral cerebral ventricle (1.2 mm caudal to bregma, 1.5 mm
+
lateral to the midline, and 4 mm below the skull surface; Houpt 1998 PMID 9437750). Guide cannulas were held in place with dental acrylic bonded to
−
lateral to the midline, and 4 mm below the skull surface).
+
stainless steel screws anchored to the skull. An obdurator was inserted into each guide cannula and remained in place
−
Guide cannulas were held in place with dental acrylic
+
except during injections when it was removed and replaced with an injector that extended 1.0 mm beyond the tip of the guide cannula.
−
bonded to stainless steel screws anchored to the skull. An
  −
obdurator was inserted into each guide cannula and remained
  −
in place except during injections when it was removed
  −
and replaced with an injector that extended 1.0 mm
  −
beyond the tip of the guide cannula.
      
===Test===
 
===Test===
−
To test the patency and placement of the cannula in the lateral ventricle,  water-replete rats were injected with 100 ng human angiotensin II (Ang II; Sigma Chemical Co, St Louis, MO) dissolved in 5 µl volume of saline (0.15 M). The volume of all icv injections was 5 µl, delivered over 30s with a handheld 50 µl syringe (Hamilton Co, Reno, NV). Immediately after the ICV injection, rats were returned to their home cage with access to a water bottle. The latency to drink was recorded; rats that failed to drink within 2 minutes of the angiotensin II injection were dropped from the study. Cannula placements were also verified postmortem by sectioning through the brain. ICV injections of 5 µl  volume were given by hand to lightly restrained rats using a 50 µl Hamilton microsyringe.  
+
To test the patency and placement of the cannula in the lateral ventricle,  water-replete rats were injected with  
 +
100 ng human angiotensin II (Ang II; Sigma Chemical Co, St Louis, MO) dissolved in 5 µl volume of saline (0.15 M).  
 +
The volume of all icv injections was 5 µl, delivered over 30s with a handheld 50 µl syringe (Hamilton Co, Reno, NV).  
 +
Immediately after the ICV injection, rats were returned to their home cage with access to a water bottle.  
 +
The latency to drink was recorded; rats that failed to drink within 2 minutes of the angiotensin II injection were  
 +
dropped from the study. Cannula placements were also verified postmortem by sectioning through the brain.  
 +
ICV injections of 5 µl  volume were given by hand to lightly restrained rats using a 50 µl Hamilton microsyringe.  
    +
==Fourth Ventricular Cannula:==
    +
3.2 mm caudal to lambda
 +
 +
0 mm lateral to the midline
 +
 +
7.2 mm below the skull surface
 +
 +
Plastics One Cannula:
 +
 +
===Method===
 +
Under isoflurane anesthesia, each rat was stereotaxically implanted with a single 22-gauge stainless steel guide cannula
 +
(model C315G; Plastics One, Inc., Roanoke, VA) aimed towards the fourth ventricle (4V).  The tip of the guide cannula
 +
was positioned on the midline 3.2 mm caudal to lambda and 7.2 mm below the skull surface (stereotaxic coordinates
 +
taken from (Baird et al. 2009 PMID 19008313)). Guide cannulas were held in place with dental acrylic bonded to stainless
 +
steel screws anchored to the skull. An obdurator  (model C315DC; Plastics One, Inc.) extending 1.0 mm beyond the guide
 +
cannula was inserted into each guide cannula and remained in place except during injections when it was removed and
 +
replaced with a XXX-gauge injector that extended 1.0 mm beyond the tip of the guide cannula.
 +
 +
===Test===
 +
To test the patency and placement of the cannula in the lateral ventricle,  water-replete rats were injected with
 +
XXX ng bombesin (California Peptides) dissolved in 5 µl volume of saline (0.15 M). The volume of all icv injections
 +
was 5 µl, delivered by hand over 30s to lightly restrained rats using a  50 µl Hamilton microsyringe (Hamilton Co, Reno, NV). 
 +
Immediately after the ICV injection, rats were returned to their home cage with access to a water bottle.
 +
The latency to initiate and duration of grooming was recorded; rats that failed to groom within 2 minutes of the
 +
bombesin injection or groomed for less than XXX minutes were  dropped from the study. Cannula placements were
 +
also verified postmortem by sectioning through the brain.
     

Navigation menu